Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Factor VII-activating protease in patients with acute deep venous thrombosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Joint Mobility and Physical Function of Danish Hemophilia Patients: A Three-Wave Panel Study Spanning 24 Years

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prenatal genetic testing by late amniocentesis to guide delivery management in haemophilia carriers

    Research output: Contribution to journalLetterResearchpeer-review

  3. Factor levels in carriers of haemophilia are associated with familial severity: a Danish single centre study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Johannes J Sidelmann
  • Frank Vitzthum
  • Eva Funding
  • Anna-Marie B Münster
  • Jørgen Gram
  • Jørgen Jespersen
View graph of relations

Factor VII-activating protease (FSAP) is involved in haemostasis and inflammation. FSAP cleaves single chain urokinase-type plasminogen activator (scu-PA). The 1601GA genotype of the 1601G/A polymorphism in the FSAP gene leads to the expression of a FSAP variant with reduced ability to activate scu-PA, without affecting the ability to activate coagulation Factor VII (FVII). Previous studies have investigated the association of the 1601GA genotype with incidence and progression of carotid stenosis and deep venous thrombosis (DVT). The present study is the first to evaluate the potential association between the FSAP phenotype and DVT. We studied the association between the 1601G/A polymorphism, FSAP activity, FSAP antigen, Factor VIIa (FVIIa), prothrombin fragment 1+2 (F1+2), and C-reactive protein (CRP) in plasmas of 170 patients suspected for DVT. FSAP genotypes were equally distributed in patients with (n=64) and without DVT (n=106), (P=0.94). The 1601GA genotype was associated with significant reduction of FSAP activity (P<0.001) and FSAP antigen levels (P=0.04). Patients with DVT showed significantly higher FSAP activity (P=0.008), FSAP antigen (P=0.003), and F1+2 levels (P<0.001) than patients without DVT. The association between the FSAP measures and DVT disappeared when adjusted for CRP levels. F1+2 correlated positively to FSAP antigen (P=0.01), while FVIIa-levels were comparable in patients with and without DVT. We conclude that even though FSAP measures are significantly increased in patients with acute DVT, alterations in the scu-PA activating properties of FSAP are presumably not markedly involved in the development of acute DVT, and that the association between FSAP and DVT disappears after adjustment for CRP.

Original languageEnglish
JournalThrombosis Research
Volume122
Issue number6
Pages (from-to)848-53
Number of pages6
ISSN0049-3848
DOIs
Publication statusPublished - 2008

    Research areas

  • Acute Disease, C-Reactive Protein, Genotype, Humans, Polymorphism, Genetic, Serine Endopeptidases, Venous Thrombosis

ID: 46003405